In combining the precision of the twiist insulin delivery system with the unmatched longevity of Eversense 365, Sequel and Senseonics are enhancing diabetes management by offering more tools to manage ...

A fault in J&J MedTech’s CEREPAK detachable coils, used in intracranial aneurysm embolisation procedures, has been associated ...

This stock has climbed in the triple digits in recent years.

Founder and CEO Christian Espinosa Will Join Panel on Data Governance and Patient Safety for Scalable HealthTech in the ...

Medtech startups struggle with funding as strategic buyers consolidate, preferring fully developed products over early investments. What can innovators do?

Many healthcare medtech companies see ASCs as a top opportunity, and in recent years they’ve been looking for direct ways to get into the facilities. One are where this is clearest is orthopedics. For ...

Medtronic achieved 8.7% revenue growth in its fiscal third quarter, reaching $9 billion for its highest growth in 10 quarters. Among other factors, the growth was driven by the company’s cardiac ...

Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of J&J’s ...

Coherent Sine-Burst Electroporation™ Platform demonstrates 100% procedural success and high freedom from AF in paroxysmal and persistent ...

Johnson & Johnson MedTech (NYSE:JNJ) today announced 12-month pilot data from a study of its investigational Omnypulse ...

Argá Medtech today announced positive findings from a first-in-human study of its Coherent Sine-Burst Electroporation (CSE) system.